Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 103 publications
Pegtarazimod limits acute graft-versus-host disease mortality and severity in mice and is tolerated in patients.
Journal: The Journal of clinical investigation
Published: August 04, 2026
MAGIC Composite Score Predicts Outcomes of Second-Line Therapy for Acute GVHD.
Journal: medRxiv : the preprint server for health sciences
Published: July 29, 2026
Real-World Analysis of Post-Transplant Cyclophosphamide on Allogeneic HCT Landscape.
Journal: Transplantation and cellular therapy
Published: June 24, 2026
Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRM.
Journal: Blood immunology & cellular therapy
Published: May 15, 2026
REG3α is a Predictive Biomarker of Complicated Disease from Preclinical through Established Crohn's Disease.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: January 27, 2026
How does one health fit into current academic frameworks? Insights from a SWOT analysis by the North America One Health University Network.
Journal: Frontiers in medicine
Published: August 18, 2025
Performance of Treatment Response Assessment at Day 7 by Baseline Acute Graft-versus-Host Disease Severity.
Journal: Transplantation and cellular therapy
Published: July 31, 2025
Differential effects of GVHD therapies on intestinal epithelium.
Journal: Blood advances
Published: May 16, 2025
Differential effects of GVHD therapies on intestinal epithelium.
Journal: Blood advances
Published: May 16, 2025
Last Updated: 09/26/2026